A new therapeutic approach for the treatment of sepsis

Medical Hypotheses

Volumn 62, Issue 3, 2004, Pages 342-345

  Iskit, Alper B ^a   Guc, M Oguz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CANAVANINE; ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTERIAL PRESSURE; DRUG MECHANISM; FATALITY; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASOCONSTRICTION; VASODILATATION;

EID: 1642387464     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.11.009     Document Type: Article

References (31)

1. Groeneveld ABJ, Thijs LG. Haemodynamic determinants of mortality in human septic shock. Surgery 1986;99:140-52.
2. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328(20):1471-7.
3. Guc MO. Vascular responsiveness to vasoactive agents in endotoxaemia. PhD thesis. University of Strathclyde, Glasgow, United Kingdom.
4. Guc MO. Review: Endotoxin-endothelium interactions in "low-perfusion state" research. J Physiol Pharmacol 1999;50:541-50.
5. Iskit AB, Sungur A, Gedikoglu G, Guc MO. The effects of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice. Eur J Pharmacol 1999;379:73-80.
6. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994;28:34-9.
7. Iskit AB, Guc MO. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia and survival in experimental models of septic shock. Acta Pharmacol Sin 2003;24:953-7.
8. Sanai L, Haynes WG, MacKenzie A, Grant IS, Webb DJ. Endothelin production in sepsis and the adult respiratory distress syndrome. Intensive Care Med 1996;22:52-6.
9. Morise Z, Ueda M, Aiura K, Endo M, Kitajima M. Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 1994;115(2):199-204.
10. Montagnani M, Potenza MA, Rinaldi R, Mansi G, Nacci C, Serio M, et al. Functional characterization of endothelin receptors in hypertensive resistance vessels. J Hypertens 1999;17(1):45-52.
11. Ahlborg G, Weitzberg E, Lundberg JM. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans. J Appl Physiol 1995;79(1):141-5.
12. Liu S, Adcock IM, Old RW, Barnes PJ, Evans TW. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 1993;196:1208-13.
13. Nava E, Palmer RM, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991;338(8782-8783):1555-7.
14. Wang P, Zheng F, Chaudry IH. Endothelium-dependent relaxation is depressed at the macro-and microcirculatory levels during sepsis. Am J Physiol 1995;269:R988-94.
15. Guc MO, Furman BL, Parratt JR. Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol 1990;101:913-9.
16. Ylmaz G, Gursoy-Ozdemir Y, Dogan AI, Gurdal H, Dalkara T, Guc MO. Spleen damage in endotoxaemic mice: The involvement of nitric oxide. J Physiol Pharmacol 2001;52:729-44.
17. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995;114(8):1666-72.
18. Fatehi-Hassanabad Z, Burns H, Aughey EA, Paul A, Plevin R, Parratt JR, et al. Effects of L-canavanine, an inhibitor of inducible nitric oxide synthase, on endotoxin mediated shock in rats. Shock 1996;6(3):194-200.
19. Liaudet L, Fishman Dr, Markert M, Perret C, Feihl F. L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia. Am J Respir Crit Care Med 1997;155:1643-8.
20. Baykal A, Iskit AB, Kaynaroglu V, Guc MO, Sayek I, Sanac Y. Effects of adrenaline or endotoxin tolerance states on mesenteric blood flow in endotoxaemia. Aus N Z J Surg 1999;69:134-7.
21. Kavuklu B, Iskit AB, Guc MO, Ilhan M, Sayek I. Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivity. Br J Surg 2000;87:448-53.
22. Baykal A, Kavuklu B, Iskit AB, Guc MO, Hascelik G, Sayek I. An experimental study of the effect of nitric oxide inhibition on mesenteric blood flow and interteukin-10 levels in lipopolysaccharide. World J Surg 2000;24(9): 1116-20.
23. Baykal A, Iskit AB, Hamaloglu E, Guc MO, Hascelik G, Sayek I. Melatonin modulates mesenteric blood flow and TNF alfa concentrations after lipopolysaccharide challenge. Eur J Surg 2000;166:722-7.
24. Navaratnam RL, Morris SE, Traber DL, Flynn J, Woodson L, Linares H, Herndon DN. Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT). J Trauma 1990;30(9):1104-13.
25. Baykal A, Kaynaroglu V, Iskit AB, Guc MO, Hascelik G, Sayek I, Sanac Y. Adrenaline tolerance does not prevent bacterial translocation in a murine burn model. Int Surg 2000;85:18-22.
26. Clozel M, Breu V, Gray GA, Kalina B, Loffer B-M, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-35.
27. Krejci V, Hiltebrand LB, Erni D, Sigurdsson GH. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 2003;31(1):203-10.
28. Mitolo-Chieppa D, Serio M, Potenza MA, Montagnani M, Mansi G, Pece S, Jirillo E, Stoclet J-C. Hyporeactivity of mesenteric vascular bed in endotoxin-treated rats. Eur J Pharmacol 1996;309:175-82.
29. Groeneveld ABJ, Kester ADM, Nauta JJP, Thijs LG. Relation of arterial blood lactate to oxygen delivery and haemodynamic variables in human shock states. Circ Shock 1987;22:35-41.
30. Van Lambalgen AA, Van Den Bos GC, Thijs LG. Changes in regional plasma extravasation in rats following endotoxin infusion. Microvascular Res 1987;34:116-32.
31. Iskit AB, Guc MO. The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock. Eur J Pharmacol 2001;414:281-7.